Form EFFECT Galmed Pharmaceuticals
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 8, 2025 |
| Accession Number: | 0001641172-25-002375 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bilt Expands Bilt OS for Hospitality, Now for Travel Advisors
- The Hideaway Opens Reservations For Luxury Garage Condominiums In North Phoenix
- A Look Into the ALJ's Crystal Ball: What the DEA Marijuana Hearing Record May Be Telling Us
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
